36R-93653-59405
4 vaccinations
5 coded responses
31 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 931 / CA
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-02-05
Registered in v-safe
- 2021-02-05
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-12
- 2021-04-29
- 2021-07-29
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-28
Survey response — days 1–6 daily, dose 3MedDRA: Body temperature increased, Decreased appetite — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: No appetite, not quite nausea, feel feverish but temp 99 (normal for me 97.2)MedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-29
- 2022-03-28
-
2022-05-06
Dose 4 — Moderna
-
2022-05-14
Survey response — day 7, dose 4MedDRA: Pre-existing disease — Feeling: Good · Muscle or body aches, Fatigue or tirednessFree text: May be due to my fibromyalgiaMedDRA releases: 2024-11 · check-in free text available
- 2022-05-20
- 2022-05-27
- 2022-06-07
- 2022-06-11
-
2022-06-17
Survey response — day 42, dose 4MedDRA: Ageusia, Anosmia, Chills, Dizziness, Ear congestion, Fatigue, Hypoacusis, Nausea, Pain, Paranasal sinus discomfort, Pyrexia, Unevaluable event, Vomiting — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fever, chills, body aches, fatigue, ST, sinus pressure, ear congestion, decreased hearing, lightheaded, N/V, loss smell/tasteMedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia, COVID-19, Dyspnoea, Eye paraesthesia, Fatigue, Hypoaesthesia, Hypoaesthesia eye, Hypoaesthesia oral, Intranasal hypoaesthesia, Intranasal paraesthesia, Paraesthesia, Paraesthesia oral, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covid positive 6/11/22, did not test negative till 6/22/22. Persistent symptoms. Fatigue, SOB, ongoing taste and smell disruptions, numbness/paresthesias primarily L side of nose, inside L nares, L tongue, L chin, occasionally up to L eye.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-06
-
2023-05-06
Survey response — 12 months, dose 4MedDRA: COVID-19, Paraesthesia — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-06 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): No appetite, not quite nausea, feel feverish but temp 99 (normal for me 97.2)
Release 11 — day 7, dose 4
Systemic reaction (other): May be due to my fibromyalgia
Release 12 — day 42, dose 4
Symptoms: Fever, chills, body aches, fatigue, ST, sinus pressure, ear congestion, decreased hearing, lightheaded, N/V, loss smell/taste
Release 12 — 3 months, dose 4
Symptoms: Covid positive 6/11/22, did not test negative till 6/22/22. Persistent symptoms. Fatigue, SOB, ongoing taste and smell disruptions, numbness/paresthesias primarily L side of nose, inside L nares, L tongue, L chin, occasionally up to L eye.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Ear congestion | · | · | ✓ |
| SD | Eye paraesthesia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypoacusis | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Hypoaesthesia eye | · | · | ✓ |
| SD | Hypoaesthesia oral | · | · | ✓ |
| SD | Intranasal hypoaesthesia | · | · | ✓ |
| SD | Intranasal paraesthesia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Paraesthesia oral | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Body temperature increased | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release